<DOC>
	<DOCNO>NCT00143845</DOCNO>
	<brief_summary>The purpose study determine whether reduced intensity condition regimen stem cell transplant donor cell allow donor cell effective without cause health problem .</brief_summary>
	<brief_title>Study Low-Intensity Conditioning Allogeneic Stem Cell Transplant</brief_title>
	<detailed_description>In research study patient receive dosage chemotherapy low usual dosage . The study determine whether short duration immunosuppression permit donor cell effective cancer without cause severe GVHD ( Graft Versus Host Disease ) . Also determine whether patient 's cancer prevent relapse blood stem cell transplant use prophylactic treatment , give donor leukocyte infusion BEFORE relapse happens . In research study sample blood bone marrow analyze . These sample examine study cellular production inflammatory cytokine level attempt able predict patient complication like GVHD relapse .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Patient To eligible patient MUST meet least one next 4 criterion Any patient age 55 year old hematological malignancy allogeneic transplant consider appropriate treatment , AND/OR Any patient , regardless age , hematologic malignancy allogeneic transplant consider appropriate treatment patient eligible conventional myeloablative transplant organ dysfunction AND/OR Any patient , regardless age , relapse follow prior autologous allogeneic transplant hematologic malignancy AND/OR Any patient , regardless age , one follow hematological malignancy : 1 . Multiple myeloma 1. refractory failure follow conventional chemotherapy VAD ( Vincristine , Adriamycin Dexamethasone ) , pulse decadron , alkylating agent , 2. chromosomal abnormality associate poor prognosis cytogenetics FISH probe . 2 . Chronic lymphocytic leukemia patient , Rai stage 3 4 relapsed following/refractory alkylating agent nucleoside analog therapy 3 . Low grade lymphoma ( small lymphocytic , follicular small cleave cell , follicular mix small cleave large cell ) either relapsed refractory provide disease NOT rapidly progressive , NOT bulky , mass exceed 5 cm great dimension . To eligible patient MUST meet follow criterion In addition criterion ALL patient must meet follow minimum organ function : 1 . Cardiac : Ejection fraction least 30 % . 2 . Renal : Adequate renal function define creatinine &lt; 2.0mg OR creatinine clearance &gt; 40 mg/min 24hour urine collection GFR ( Glomerular Filtration Rate . ( Gender ageadjusted creatinine clearance &gt; 40ml/min GaultCockroft 55 acceptable adult : ( 140 age ) x weight/72 x Scr [ x 0.85 female ] ) . 3 . Pulmonary : FEV1 FVC &gt; 60 % . 4 . Hepatic : Total bilirubin &lt; 2.0 AST ( Aspartate Aminotransferase ) /ALT ( Alanine Transaminase ) &lt; 3X institutional normal age . 5 . Performance ( adult ) : Karnofsky score must least 60 ; pt . 16 , Lansky score must least 60 . Availability 5/6 6/6 HLA A , B , DR identical relative willing able donate allogeneic stem cell . Serological , low resolution mid resolution molecular type determine degree match HLA ( Human Leukocyte Antigen ) class I regardless high resolution DNA typing result . High resolution type use determine degree match HLADR . No untreated uncontrolled invasive infection . Patients still therapy presumed proven infection eligible provide clear evidence ( radiologic and/or culture ) infection well control . Patients treatment infection enrol clearance Principal Investigator . Not pregnant Patient acute leukemia HIV positive patient eligible Any physical psychological condition , opinion investigator , would pose unacceptable risk patient Pregnant Donor 5/6 6/6 HLA match HLAA , B , DR Age 370 year , good general health No contraindication GCSF ( Granulocyte ColonyStimulating Factor ) stimulation No contraindication leukapheresis peripheral blood stem cell Good general health Donor HIV positive history HIV risk factor Presence diseases transmissible blood pose unacceptable risk study subject . Pregnant Medical psychological condition would make donor unlikely tolerate GCSF injection leukapheresis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>